The Official MicroCap News Source
Watchlist News
Please Login or Register to view News Stories

Cyclacel Pharmaceuticals, Inc. - Biopharmaceutical Company Developing Medicines Based on Cancer Cell Biology Discusses Growth Drivers

SNNLive spoke with Spiro Rombotis, President and CEO of Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC) at the Dawson James Small Cap Growth Conference 2018 in Jupiter, FL.

Share With

Thursday, January 10, 2019


© 2020 Stock News Now